Evaluation of antiphospholipid antibody assays using latent class analysis to address the lack of a reference standard

被引:3
|
作者
Thaler, Markus A. [1 ]
Bietenbeck, Andreas [1 ]
Yin, Meng-Xin [2 ]
Steigerwald, Udo [3 ]
Holmes, Andrew B. [2 ]
Lindhoff-Last, Edelgard [4 ]
Luppa, Peter B. [1 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, Ismaninger Str 22, D-81675 Munich, Germany
[2] Univ Melbourne, Sch Chem, Inst Bio21, Parkville, Vic, Australia
[3] Univ Klinikum Wurzburg, Zent Lab, Zentrum Innere Med A4, Wurzburg, Germany
[4] Cardioangiol Ctr Bethanien, Coagulat Res Ctr CCB, Frankfurt, Germany
基金
澳大利亚研究理事会;
关键词
antiphospholipid antibodies; biosensor; latent class analysis; method evaluation; surface plasmon resonance; ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES; 13TH INTERNATIONAL-CONGRESS; EXTERNAL QUALITY-ASSURANCE; ANTICARDIOLIPIN ANTIBODIES; LABORATORY DIAGNOSIS; CLASSIFICATION CRITERIA; CLINICAL-PERFORMANCE; EUROPEAN FORUM; CONSENSUS; IGG;
D O I
10.1515/cclm-2016-0116
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Method evaluation of new assays for the detection of antiphospholipid antibodies (aPL) such as anti--cardiolipin (aCL) or anti-beta(2)-glycoprotein I (a beta(2)-GPI) is challenging, as no internationally accepted reference material is available yet. Besides a lack of standardization, unacceptable inter-laboratory comparability of established tests is regularly observed. Owing to the absence of a commonly accepted reference standard, the evaluation of two research surface plasmon resonance (SPR) biosensor assays was performed using statistical methods from latent class analysis (LCA). Methods: aCL and a beta(2)-GPI IgG and IgM were measured in sera from 63 antiphospholipid syndrome patients, fulfilling the Sydney criteria, and in 34 healthy controls with four commercial assays. LCA was performed on the results and sera were assigned to the antibody-positive or antibody- negative group. Sera were subsequently evaluated in the SPR assays for aCL and a beta(2)-GPI. Optimal cutoffs and diagnostic performances of the research systems were established employing the LCA-derived gold standard. Results: With area under the curve results of 0.96 and 0.89 for the detection of aCL and a beta(2)-GPI, the research SPR assays discriminated well between antibody-positive and antibody-negative sera. Their sensitivities and specificities were comparable to the investigated commercial immunoassays. Conclusions: SPR assays are a suitable tool for the detection of aCL and a beta(2)-GPI with diagnostic performances not different from currently available commercial tests. LCA enabled the calculation of sensitivities and specificities for aPL assays in absence of a reference standard.
引用
收藏
页码:1929 / 1937
页数:9
相关论文
共 50 条